We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Urine Osmolality Measurement Evaluated on Automated Analyzer

By LabMedica International staff writers
Posted on 06 Oct 2020
Print article
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Image: The UF-5000 fully automated flow cytometer based on renowned fluorescence flow cytometry (FFC), represents the latest in urinalysis technology (Photo courtesy of Sysmex Corporation).
Urinalysis is a convenient and non‐invasive screening tool for use in both an outpatient and inpatient setting. Automated flow cytometry‐based urine analyzer is increasingly being used to identify and enumerate cells and particles in urine specimens. It measures electrical conductivity which could be transformed to osmolality.

The osmolality of urine, which indicates the quantity of osmotically active particles, can be estimated by the specific gravity (SG). While the SG correlates with urine osmolality, the direct measurement of urine osmolality is more accurate and is considered the gold standard for determining the hydration status of the body and its ability to concentrate urine.

Laboratory Medical Scientists at the Pusan National University Yangsan Hospital (Yangsan, South Korea) collected 270 random urine samples, also known as spot samples, for analysis that included osmolality testing from May 2018 to July 2018. The precision of urine osmolality measurement by the UF‐5000 (Sysmex Corporation, Kobe, Japan) was evaluated for 20 days and four times a day for two concentrations. The linearity and detection capability were evaluated according to the Clinical and Laboratory Standards Institute guidelines. A comparison analysis between the UF‐5000 and the OsmoPro equipment (Advanced Instruments, Norwood, MA, USA) was performed in the laboratory using random urine samples from patients.

The laboratorians reported that the laboratory‐based coefficient variations were less than 5%. Urine osmolality using the UF‐5000 has a verified linear range (R2 = 0.997). Within the comparison analysis, the mean difference was not large (−7.72%), but each differences were largely dispersed with 95% limits of agreement (LoA) from −70.5 to 55.06%, and the mean absolute difference −28.3 mOsm/kg with 95% LoA from −295.13 to 238.45 mOsm/kg. Cohen's kappa value was 0.54. The mean ± SD osmolality measured by the OsmoPro and UF5000 was 450.33 ± 227.51 mOsm/kg and 421.99 ± 221.53 mOsm/kg, respectively.

The authors concluded that the conductivity‐based measurement of osmolality has reliable precision and linearity within a specific range that includes the reference range. Considering the good accessibility of routine analyzer, UF‐5000 can be used to determine whether the urine osmolality is within the reference or should be measured by freezing depression method. The study was published on September 24, 2020 in the Journal of Clinical Laboratory Analysis.

Related Links:
Pusan National University Yangsan Hospital
Sysmex Corporation
Advanced Instruments


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Respiratory QC Panel
Assayed Respiratory Control Panel

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.